Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T(3-4a)N0M0 Gastric Cancer Patients after D2 Gastrectomy

Aim. To investigate whether tumor size is a reasonable indication for adjuvant chemotherapy for T(3-4a)N0M0 gastric cancer patients after D2 gastrectomy. Method. We performed a retrospective study of 269 patients with a histological diagnosis of T(3-4a)N0M0 stage gastric cancer who underwent D2 radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shi, Ou-Yang, Li-Ying, Nie, Run-Cong, Li, Yuan-Fang, Xiang, Jun, Zhou, Zhi-Wei, Chen, Ying-Bo, Peng, Jun-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346364/
https://www.ncbi.nlm.nih.gov/pubmed/28331491
http://dx.doi.org/10.1155/2017/4928736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346364/
https://www.ncbi.nlm.nih.gov/pubmed/28331491
http://dx.doi.org/10.1155/2017/4928736

Ejemplares similares